Teligent, Inc. To Present At Oppenheimer 27th Annual Healthcare Conference On March 22, 2017

BUENA, N.J., March 22, 2017 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Oppenheimer 27^th Annual Healthcare Conference. The Conference is taking place on March 21-22, 2017 at the Westin New York Grand Central, New York, NY.

Jason Grenfell-Gardner, President and CEO of Teligent, Inc. will present on Wednesday, March 22, 2017 at 1:00 p.m. ET. 

The presentation will be webcast and will be accessible online on the investors section of the Company's website at http://www.teligent.com.  A replay will be available for 30 days.  

About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company.  Our mission is to be a leading player in the specialty generic prescription drug market.  Learn more on our website www.teligent.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/teligent-inc-to-present-at-oppenheimer-27th-annual-healthcare-conference-on-march-22-2017-300427235.html

SOURCE Teligent, Inc.